Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC.

Saved in:
Bibliographic Details
Title: Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC.
Authors: Gammelgaard KR; Department of Biomedicine, Aarhus University, Aarhus, Denmark; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark., Vad-Nielsen J; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Clement MS; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark., Weiss S; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Daugaard TF; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Dagnæs-Hansen F; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Meldgaard P; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Sorensen BS; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark., Nielsen AL; Department of Biomedicine, Aarhus University, Aarhus, Denmark. Electronic address: aln@biomed.au.dk.
Source: Translational oncology [Transl Oncol] 2019 Mar; Vol. 12 (3), pp. 432-440. Date of Electronic Publication: 2018 Dec 16.
Publication Type: Journal Article
Journal Info: Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1936-5233
DOI:10.1016/j.tranon.2018.11.017